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Introduction
Migraine is a chronic, progressive, and debili-
tating disorder that has an impact on the lives of
millions of individuals. The origins of the disability
can be traced into childhood and adolescence for
most adult migraine sufferers(1). 
In the twentieth century, clinical reports have
been recognized some migraine precursors occur-
ring from infancy to adolescence that lack a promi-
nent headache component(2, 3). These specific syn-
drome complexes have been labeled migraine
equivalents, or periodic syndromes of childhood
with a decrease in frequency and duration linked to
growth.
These are thought to share a pathogenetic and
causal relationship to more typical childhood
migraines by their periodic nature, similarity to
more well-established adult migraine syndromes,
backdrop of a strong family history of migraines in
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ABSTRACT
Background: Migraine is a chronic, progressive, and debilitating disorder that has an impact on the lives of millions of indivi-
duals. The origins of the disability can be traced into childhood and adolescence for most adult migraine sufferers. The group
of periodic syndromes consists in symptoms related to migraine, thought to be migraine equivalent or precursors.
Aim of this study is to assess the role of MS as risk factors for childhood migraine.
Materials and methods: 441 subjects (211 Females) aged 6-13 years (mean 9.20; SD 2.42), consecutively referred between
October 2007 to March 2009 for primary headaches to pediatric Centers for Headache in Childhood. Control group consisted
of 365 subjects (175 F) aged 7-13 years (mean 9.08; SD 3.02).
Results: Two groups were not different for age (F=0.390; p=0.539) and sex ratio (Chi-square=0.002; p=0.966). Headache
percentage distribution was the following: MoA 38.32%, MA 11.11%, FETTH 16.78%, CTTH 20.63%. Logistic regression shows a
greater OR for CVS and MS associated for migraine group (MoA and MA patients), respectively 8.28 (IC95% 2.35 - 29.16) for CVS
and 5.22 (IC95% 3.5 - 7.77); moreover, CVS cause a consistent increase in OR of 3.69 (IC95% 2.21 - 6.17) also for headache group
(CTTH and FETTH patients).
Discussion: Periodic syndromes could be considered the natural precursors of migraine almost but not only in children, as
reported in some studies in adulthood.
Keywords: childhood migraine, periodic syndromes, Abdominal Migraine, Motion Sickness, Cyclic Vomiting, Growing Pains.
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the affected child, and the later evolution in the
individual child to more typical migraines(4). 
Synthetically, the group of periodic syndromes
consists in symptoms related to migraine, thought
to be migraine equivalent or precursors. 
The International Headache Society (IHS) cri-
teria(5) computed only three “periodic syndromes”
as precursors of migraine: Cyclical Vomiting
Syndrome (CVS) [G43.82] (Table1), Abdominal
Migraine (AM) [G43.820], Benign Paroxysmal
Vertigo of childhood  (BPV) [G43.821]. In clinical
practice, it’s well known that also other recurrent
syndromes such as Growing Pains (GP), Periodic
Fever (PF) and sleep disorders are very frequent in
children with migraine, particularly in paediatric
age range. 
Moreover, CVS and AM are relatively unusual
periodic syndromes, characterized by recurrent and
severe paroxysmal episodes of vomiting and/or
abdominal pain lasting hours to days separated by
weeks to months of no symptoms. Anyway, it’s
important to pinpoint that AM includes also a sub-
set of patients with chronic recurrent abdominal
pain who have features that overlap with those of
migraine without aura (MoA)(6).
Although these syndromes have been known
for decades(7, 8), their suggested relationship to
migraine remains a matter of debate. 
For example, regarding sleep disorders, it’s
interesting to note that migraineous children show a
variety of sleep troubles such as parasomnias, sleep
breathing disorders and excessive daytime sleepi-
ness as reported in literature and confirmed by
polysomnographic findings(9, 10). On this perspective,
also sleep disorders could be considered precursor
of migraine because are frequent in intercritical
periods and their resolution could improve sensibly
migraine symptoms such as pain intensity and tem-
poral duration of attacks.
Another syndrome strictly associated with
migraine is Motion Sickness (MS), a condition
dominated by disagreement between visually per-
ceived movement and the vestibular system’s sense
of movement. The most common symptoms MS are
dizziness, fatigue, and nausea. MS is not coded in
the actual IHS classification as migraine precursor
or migraine equivalent, even if MS was reported in
children with recurrent vomiting suggesting a pre-
disposition for developing migraine(11).   
Aim of this study is to assess the role of MS as
risk factors for childhood migraine.
Materials and methods
Study population consists of 441 subjects (211
F) aged 6-13 years (mean 9.20; SD 2.42), consecu-
tively referred between October 2007 to March
2009 for primary headaches to pediatric Center for
Headache in Childhood. 
Headache types were diagnosed according
IHS-2004 criteria by an expertise clinicians. In
headache group were diagnosed only Chronic ten-
sion-type headache (CTTH) and Frequent Episodic
Tension-Type Headache (FETTH); in migraine
group were diagnosed Migraine with Aura (MA)
and Migraine without Aura (MoA).  
In order to select only patients with primary
headaches, each patient was evaluated by clinical
interview and examination as well by neurophysio-
logical recordings (wake and sleep EEG) and neu-
roimaging assessment (TC scan and MRI).
Exclusion criteria were neurological (i.e.
epilepsy, cerebral tumors, movement disorders),
psychiatric (i.e. anxiety, depression, eating disor-
ders) and muscular disorders, otolaryngology prob-
lems (i.e. vestibular alterations, Meniere syndrome,
otitis), gastrointestinal diseases, rheumatic arthritis.
All subjects and parents of both groups were inter-
viewed about the presence of migraine equivalents
with an ad hoc questionnaire.
Results were compared with findings obtained
in a control group of 365 subjects (175 F) aged 7-
13 years (mean 9.08; SD 3.02), recruited in local
schools of Campania region. Informed consent was
obtained from all parents’ subjects and from chil-
dren of both groups.   
Statistical analysis
Chi-square test and logistic regression were
performed in both group to assess the difference in
prevalence and the role of single migraine precursor
1242 Agata Maltese, Beatrice Gallai et Al
Migraine (n=218) Headache (n=165)
OR IC95% OR IC95%
MS 5,22 3,5 - 7,77 0,90 0,52 - 1,55
CVS 8,28 2,35 - 29,16 4,74 1,88 – 11,98
AM 2,82 1,71 - 4,65 3,69 2,21 – 6,17
GP 3,63 2,22 - 5,93 1,78 0,99 – 3,21
Table 1: Shows the OR of each periodic syndromes in
migraine and headache subjects versus control group.
MS: Motion Sickness; CVS. Cyclic.Vomiting; AM: Abdominal
Migraine; GP: Growing Pain.
and MS as risk factor for headache and for
migraine. According to a previous Italian report
motion sickness prevalence (alone or associated
with other symptoms) in migrainous children was
61% vs. 17% of control group(12). Herein, to calcu-
late the sample size was used the online software
www.dssresearch.com/toolkit/sscalc/size_p2.asp. 
The P level was set at <0.05 for statistical sig-
nificance. All data were coded and analyzed using
the commercially available STATISTICA 6.0 pack-
age for Windows (StatSoft, Inc., Tulsa, OK).
Results 
Control group consists of 365 subjects (175 F)
aged 7-13 years (mean 9.08; SD 3.02); matched for
age (F=0.390; p=0.539) and sex ratio (Chi-
square=0.002; p=0.966). 
Headache percentage distribution was the fol-
lowing: MoA 38.32%, MA 11.11%, FETTH
16.78%, CTTH 20.63% (Figure 1). In 13.15% of
headache subjects was not possible a diagnosis
according to IHS criteria and coded as CNC
(Criteria Not Classified) and excluded from study
group. 
About PF and BPV, no one in study group and
in healthy controls was affected. 
Moreover, sleep disorders prevalence was
assessed but not computed in this study in order to
avoid a potential confounding effect.  
In healthy control group the percentage of
symptoms of periodic syndrome was the following:
MS 13.97%; CVS 1.92%; AM 8.22%; GP 7.95%.
Periodic syndromes are more prevalent in
migraine group than headache group. Moreover,
MS is strongly associated with migraine (Chi-
square = 46.217; p<0.001), as GP prevalence (Chi-
square = 6.010; p=0.014). CVS and AM shows no
statistic differences in migraine group respect of
headache subjects.  
Logistic regression shows a greater OR for
CVS and MS associated for migraine group (MoA
and MA patients), respectively 8.28 (IC95% 2.35 –
29.16) for CVS and 5.22 (IC95% 3.5 - 7.77); more-
over, CVS cause a consistent increase in OR of 3.69
(IC95% 2.21 - 6.17) also for headache group
(CTTH and FETTH patients) as summarized in
Table 1.      
In Table 2 has been shown the OR of associa-
tion of two migraine equivalents; in migraine group
the strongest association is AM plus GP with an OR
of 24.98 (IC95% 3.26 - 191.35), but the same asso-
ciation cause a significant increase in OR also in
headache group (OR 21; IC95% 2.64 - 167.17). The
association with MS causes an increase in OR in
migraine group and less in headache subjects.
Specifically, the association of MS plus CVS has an
OR of 10.30 (IC95% 1.23 - 86.15) in migraine sub-
jects and in headache group its OR is 4.47 (IC95%
0.40 - 49.61).
Moreover, MS associated with AM has an OR
of 11.16 (IC95% 3.82 - 32.64) and MS associated
with GP has OR of 9.75 (IC95% 3.68 - 25.80) both
in migraine group. In headache subjects, respective-
ly the same associations show an OR of 4.0 (IC95%
1.15 - 13.85) for MS plus AM and 1.79 (IC95%
0.47 - 6.75) for MS plus GP.     
Table 3 shows the differences in OR between
MoA and MA group and the MS increases strongly
the OR to have MoA (OR = 6.08; IC95% 3.99 -
9.28), and CVS increases strongly the OR to have
MA (OR = 5.81; IC95% 1.77 - 19.10). 
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Migraine (n=218) Headache (n=165)
OR IC95% OR IC95%
MS plus CVS 10.3 1.23 – 86.15 4.47 0.40 – 49.61
MS plus AM 11.16 3.82 – 32.64 4 1.15 – 13.85
MS plus GP 9.75 3.68 – 25.80 1.79 0.47 – 6.75
CVS plus AM 10.3 1.23 – 86.15 9.04 1.0 – 81.55
CVS plus GP 12.08 1.48 – 98.83 4.47 0.40 – 49.61
AM plus GP 24.98 3.26 – 191.35 21 2.64 – 167.17
Table 2: Shows the OR of association of two migraine
equivalents in migraine and headache subjects versus
control group.
MS: Motion Sickness; CVS: Cyclic Vomiting Syndrome; AM:
Abdominal Migraine; GP: Growing Pain.
Migraine (n=49) Headache (n=165)
OR IC95% OR IC95% 
MS 2.99 1.53 – 5.81 6.08 3.99 – 9.28
CVS 5.81 1.77 – 19.10 2.88 1.05 – 7.86
AM 3.62 1.71 – 7.67 2.61 1.53 – 4.46
GP 4.63 2.24 – 9.59 3.36 1.99 – 5.67
Table 3: shows the OR of each migraine equivalent in
migraine without aura (MoA) and in migraine with aura
(MA) subjects versus control group.
MS: Motion Sickness; CVS: Cyclic Vomiting Syndrome; AM:
Abdominal Migraine; GP: Growing Pain. 
Discussion
Periodic syndromes could be considered the
natural precursors of migraine almost but not only
in children, as reported in some studies in adult-
hood(13-15).
In school-aged children there are only few
reports and the prevalence of migraine precursors in
a large paediatric sample could be estimated in 68%
for BPV and 65% for AM associated with CVS in
positive family history of migraine children(16).
In a previous Italian paediatric samples(11), in
migraine children the prevalence of CVS was 40%
and AM was 30%, differing from our findings
(respectively 6.42% for CVS and 20.18% for AM).
A possible explanation in this difference could be
found in difficulty in discriminating the symptoms
of CVS and AM from signs of irritable bowel syn-
drome, frequent in children particularly with
migraine(16, 17). In our study, MS has been strongly
associated with migraine symptoms, particularly
with MoA as reported by Lanzi et al.(11). 
MS results in a variety of symptoms, including
dizziness, nausea, cold sweat, pallor, lethargy,
headache and can be induced by motion alone or
conflicts among difference balance systems, includ-
ing vestibular, visual, and proprioceptive systems. 
Actually, the phenomenon of MS has no a
clear explanation even if could be hypothesized that
is “an eliciting or reinforcing stimulus for condi-
tioned avoidance of potentially dangerous situa-
tions”(18).
Moreover, it’s well known the susceptibility of
migraineurs to symptoms induced by optokinetic
stimulation(19) with an unknown pathogenesis. 
Anyway, because serotonergic drugs with trip-
tans block emesis during motion sickness(20, 21), low
levels of serotonin in the vestibular or emetic path-
ways of migraineurs might increase susceptibility
to nausea. Moreover, an abnormal central serotonin
turnover and an associated increase in serotonin
receptor sensitivity may compromise pain modula-
tion and increase susceptibility to migraine(22; 23).
In order to our findings, when MS is associat-
ed with another migraine equivalent, the OR
increases but it seems that the weight of AM and
MS in migraine group could be similar (Table 2).  
Moreover, in MoA children the prevalence of
parasomnias is higher than control(8), how if the
alteration of serotoninergic neurotransmission typi-
cal of disorders of arousal group (i.e. sleepwalking,
sleeptalking) could be reinforced or sustained by
the similar imbalance due to migraine syndrome,
confirming the 5-HT role in MS and the effects of
triptans(21, 22).
On other hand, in MA subjects is frequent the
restless leg syndrome (RLS) linked to dysfunction
in dopaminergic systems (24-26) and related to
sympathetic hyperactivity as CVS(27-74).  
Conclusions
According to our findings, we suggest that MS
could be included into IHS classification as child-
hood periodic syndromes that are commonly pre-
cursor of migraine, considered its strong preva-
lence, its similar weight to increase the risk to
develop migraine headache and association with
others migraine equivalents in school-aged chil-
dren.
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